This pathway was discovered in cancer cells overexpressing the NF-κB target pyruvate kinase M2 (PKM2), a glycolytic enzyme which allows survival of cancer cells under low oxygen conditions (Mazurek et al., 2005; Yang et al., 2012). Here, NFKB1 is linked to cancer.